176 related articles for article (PubMed ID: 27110038)
1. NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[
Stiborová M; Indra R; Moserová M; Šulc M; Hodek P; Frei E; Schmeiser HH; Arlt VM
Monatsh Chem; 2016; 147():847-855. PubMed ID: 27110038
[TBL] [Abstract][Full Text] [Related]
2. NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene.
Stiborová M; Indra R; Moserová M; Frei E; Schmeiser HH; Kopka K; Phillips DH; Arlt VM
Chem Res Toxicol; 2016 Aug; 29(8):1325-34. PubMed ID: 27404282
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
Indra R; Moserova M; Sulc M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome
Stiborová M; Indra R; Frei E; Kopečková K; Schmeiser HH; Eckschlager T; Adam V; Heger Z; Arlt VM; Martínek V
Monatsh Chem; 2017; 148(11):1983-1991. PubMed ID: 29104319
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[
Stiborová M; Indra R; Moserová M; Bořek-Dohalská L; Hodek P; Frei E; Kopka K; Schmeiser HH; Arlt VM
Monatsh Chem; 2017; 148(11):1959-1969. PubMed ID: 29104317
[TBL] [Abstract][Full Text] [Related]
7. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome b
Reed L; Mrizova I; Barta F; Indra R; Moserova M; Kopka K; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
Arch Toxicol; 2018 Apr; 92(4):1625-1638. PubMed ID: 29368147
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5.
Indra R; Moserova M; Kroftova N; Sulc M; Martinkova M; Adam V; Eckschlager T; Kizek R; Arlt VM; Stiborova M
Neuro Endocrinol Lett; 2014; 35 Suppl 2():105-13. PubMed ID: 25638374
[TBL] [Abstract][Full Text] [Related]
10. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat.
Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M
Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716
[TBL] [Abstract][Full Text] [Related]
11. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
Reed L; Jarvis IWH; Phillips DH; Arlt VM
Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
[TBL] [Abstract][Full Text] [Related]
12. Activation and detoxification metabolism of urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone by rat and mouse hepatic microsomes.
Stiborova M; Cechova T; Borek-Dohalska L; Moserova M; Frei E; Schmeiser HH; Paca J; Arlt VM
Neuro Endocrinol Lett; 2012; 33 Suppl 3():8-15. PubMed ID: 23353838
[TBL] [Abstract][Full Text] [Related]
13. Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase.
Reed L; Jarvis IWH; Phillips DH; Arlt VM
Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503162. PubMed ID: 32265041
[TBL] [Abstract][Full Text] [Related]
14. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
[TBL] [Abstract][Full Text] [Related]
15. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
[TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
[TBL] [Abstract][Full Text] [Related]
17. Benzo[
Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
[TBL] [Abstract][Full Text] [Related]
18. Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method.
Moserová M; Kotrbová V; Aimová D; Sulc M; Frei E; Stiborová M
Interdiscip Toxicol; 2009 Dec; 2(4):239-44. PubMed ID: 21217860
[TBL] [Abstract][Full Text] [Related]
19. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
20. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
